Concepedia

TOMOAKI IWASA

TI

4

Publications

76

Citations

4

H-Index

1988

Active since

Affiliations

Fujisawa City Hospital(Current)

TOMOAKI IWASA is an author at Fujisawa City Hospital specializing in pharmacology, medicine, and nanomedicine.

Top concepts

MedicineBiochemistryNanomedicinePharmacologyDrug DeliveryBiomedical EngineeringEngineeringDrug DiscoveryLipid ChemistryMedicinal Chemistry

Publications per year

1988–1988

4

Publications

4

Liposomal sustained-release delivery systems for intravenous injection. IV. Antitumor activity of newly synthesized lipophilic 1-.BETA.-D-arabinofuranosylcytosine prodrug-bearing liposomes.

Yuji Tokunaga, TOMOAKI IWASA, Jiro Fujisaki et al. · Chemical and Pharmaceutical Bulletin · 1988 · 25 citations · Full text

Antitumor Activity, Dosage Form, Cellular Pharmacology +21

Liposomal sustained-release delivery systems for intravenous injection. II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes.

Yuji Tokunaga, TOMOAKI IWASA, Jiro Fujisaki et al. · Chemical and Pharmaceutical Bulletin · 1988 · 21 citations · Full text

Nanotherapeutics, Engineering, Unilamellar Liposomes +21

Liposomal sustained-release delivery systems for intravenous injection. I. Physicochemical and biological properties of newly synthesized lipophilic derivatives of mitomycin C.

Yuji Tokunaga, TOMOAKI IWASA, Jiro Fujisaki et al. · Chemical and Pharmaceutical Bulletin · 1988 · 20 citations · Full text

Pharmaceutical Science, Mitomycin C, Pharmaceutical Chemistry +18

Liposomal sustained-release delivery systems for intravenous injection. V. Biological disposition of liposome-entrapped lipophilic prodrug of 1-.BETA.-D-arabinofuranosylcytosine.

Yuji Tokunaga, TOMOAKI IWASA, Jiro Fujisaki et al. · Chemical and Pharmaceutical Bulletin · 1988 · 10 citations · Full text

Lipid Analysis, Pharmaceutical Science, Engineering +22

Rows per page

1–4 of 4